Insider Buy/Sell Details for the Healthcare Sector — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2000)
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
81,500
Price
$116.53
Total Value
$9.50M
Shares Held After
3,156,442
% of Holdings
2.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,639
Price
$124.61
Total Value
$204.24K
Shares Held After
534,321
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
58,205
Price
$115.57
Total Value
$6.73M
Shares Held After
3,237,942
% of Holdings
1.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,517
Price
$123.62
Total Value
$187.53K
Shares Held After
535,960
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
9,229
Price
$114.65
Total Value
$1.06M
Shares Held After
3,296,147
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
698
Price
$122.67
Total Value
$85.62K
Shares Held After
537,477
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,215
Price
$113.70
Total Value
$1.16M
Shares Held After
3,305,376
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
5,689
Price
$121.38
Total Value
$690.53K
Shares Held After
538,175
% of Holdings
1.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
719
Price
$111.89
Total Value
$80.45K
Shares Held After
3,315,591
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
15,660
Price
$120.66
Total Value
$1.89M
Shares Held After
543,864
% of Holdings
2.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
614
Price
$110.79
Total Value
$68.03K
Shares Held After
3,316,310
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
5,144
Price
$119.71
Total Value
$615.79K
Shares Held After
559,524
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,915
Price
$110.30
Total Value
$211.22K
Shares Held After
3,316,924
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
337
Price
$129.61
Total Value
$43.68K
Shares Held After
2,862,351
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,351
Price
$108.83
Total Value
$1.56M
Shares Held After
3,318,839
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,197
Price
$128.69
Total Value
$282.73K
Shares Held After
2,862,688
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
159
Price
$108.02
Total Value
$17.18K
Shares Held After
3,333,190
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
25,075
Price
$127.37
Total Value
$3.19M
Shares Held After
2,864,885
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
9,994
Price
$107.30
Total Value
$1.07M
Shares Held After
3,333,349
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,609
Price
$126.71
Total Value
$203.88K
Shares Held After
2,889,960
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,716
Price
$125.82
Total Value
$467.55K
Shares Held After
2,891,569
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
11,711
Price
$124.61
Total Value
$1.46M
Shares Held After
2,895,285
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,860
Price
$123.62
Total Value
$1.34M
Shares Held After
2,906,996
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
4,977
Price
$122.67
Total Value
$610.53K
Shares Held After
2,917,856
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
40,774
Price
$121.38
Total Value
$4.95M
Shares Held After
2,922,833
% of Holdings
1.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
112,299
Price
$120.66
Total Value
$13.55M
Shares Held After
2,963,607
% of Holdings
3.7%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
37,179
Price
$119.71
Total Value
$4.45M
Shares Held After
3,075,906
% of Holdings
1.2%
Trulieve Cannabis Corp. (TRLV)
Rivers Kim A. — Director
Shares
300,000
Price
$8.17
Total Value
$2.45M
Shares Held After
1,613,724
% of Holdings
15.7%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
5,394
Price
$20.00
Total Value
$107.88K
Shares Held After
115,005
% of Holdings
4.5%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
28,935
Price
$20.06
Total Value
$580.51K
Shares Held After
13,579
% of Holdings
68.1%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,500
Price
$119.00
Total Value
$297.50K
Shares Held After
50,195
% of Holdings
4.7%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,500
Price
$109.00
Total Value
$272.50K
Shares Held After
52,695
% of Holdings
4.5%
908 Devices Inc. (MASS)
Knopp Kevin J. — Director
Shares
16,388
Price
$9.10
Total Value
$149.13K
Shares Held After
735,623
% of Holdings
2.2%
CYTOKINETICS INC (CYTK)
Lee Sung — EVP, Chief Financial Officer
Shares
38,730
Price
$82.30
Total Value
$3.19M
Shares Held After
63,221
% of Holdings
38.0%
Hongchang International Co., Ltd (HCIL)
Lin Zhenzhu — Director
Shares
5,000
Price
$0.11
Total Value
$560.00
Shares Held After
62,253,082
% of Holdings
0.0%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
11,130
Price
$253.39
Total Value
$2.82M
Shares Held After
189,094
% of Holdings
5.6%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
5,066
Price
$252.31
Total Value
$1.28M
Shares Held After
200,224
% of Holdings
2.5%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
1,200
Price
$251.60
Total Value
$301.91K
Shares Held After
205,290
% of Holdings
0.6%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
16,204
Price
$250.25
Total Value
$4.06M
Shares Held After
206,490
% of Holdings
7.3%
ImmunityBio, Inc. (IBRX)
Simon Barry J. — Director
Shares
25,000
Price
$7.88
Total Value
$196.91K
Shares Held After
2,802,788
% of Holdings
0.9%
Natera, Inc. (NTRA)
ROSENMAN HERM — Director
Shares
16,530
Price
$250.00
Total Value
$4.13M
Shares Held After
4,250
% of Holdings
79.5%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
100
Price
$27.77
Total Value
$2.78K
Shares Held After
26,804
% of Holdings
0.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
3,400
Price
$26.98
Total Value
$91.73K
Shares Held After
26,704
% of Holdings
12.7%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
3,000
Price
$25.98
Total Value
$77.94K
Shares Held After
23,304
% of Holdings
12.9%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
2,891
Price
$25.22
Total Value
$72.91K
Shares Held After
20,304
% of Holdings
14.2%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
2,800
Price
$19.01
Total Value
$53.24K
Shares Held After
409,061
% of Holdings
0.7%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
14,565
Price
$78.41
Total Value
$1.14M
Shares Held After
245,571
% of Holdings
5.6%
Omada Health, Inc. (OMDA)
Cook Steven L. — Chief Financial Officer
Shares
2,600
Price
$19.02
Total Value
$49.44K
Shares Held After
166,659
% of Holdings
1.5%
Omada Health, Inc. (OMDA)
Gracey Craig — Chief Accounting Officer
Shares
2,083
Price
$19.01
Total Value
$39.60K
Shares Held After
5,025
% of Holdings
29.3%
Heartflow, Inc. (HTFL)
Farquhar John C.M. — Director
Shares
38,900
Price
$35.00
Total Value
$1.36M
Shares Held After
457,935
% of Holdings
7.8%
Showing 201–250 of 2000 transactions (page 5 of 40)